Scholars Central

EditorialPublished 27 Aug 2020

FDA Provides New Guidance on Antipsychotic Usage during Pregnancy

Authors: Peter F. Buckley

Clinical Schizophrenia & Related Psychoses

Volume 5 · Issue 2 · Pages 12–14

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The U.S. Food and Drug Administration (FDA), taking stock of all available and new pharmacoepidemiological information on antipsychotic medication use, has provided updated guidance on prescribing antipsychotics during and immediately after pregnancy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Schizophrenia & Related Psychoses.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Schizophrenia & Related Psychoses
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Peter F. Buckley”